This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
antibody
product name :
Anti-PCNA monoclonal antibody, clone 4H347 [Biotin]
catalog :
DCABH-9478
quantity :
50 μg
clonality :
monoclonal
host :
mouse
conjugate :
biotin
clone name :
4H347
reactivity :
human
application :
western blot, immunocytochemistry, immunoprecipitation, immunohistochemistry - paraffin section
product information
Cat :
DCABH-9478
Product Name :
Anti-PCNA monoclonal antibody, clone 4H347 [Biotin]
Brand :
Creative Diagnostics
Abbr :
Anti-PCNA MAb, Biotin-Conjugated
Host animal :
Mouse
Clone :
4H347
Official Symbol :
PCNA
Clonality :
Monoclonal
Application :
WB, IP, IHC-P, ICC/IF
Target :
PCNA
Species Reactivity :
Human
Conjugate :
Biotin
Antibody Type :
Primary Antibodies
Immunogen :
Recombinant PCNA polypetides
Alternative Names :
PCNA; proliferating cell nuclear antigen; cyclin; DNA polymerase delta auxiliary protein; MGC8367;
UniProt ID :
P12004
Antibody Isotype :
IgG2a
Size :
50 μg
Storage :
Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle.
company information
Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments